Dublin, July 04, 2023 (GLOBE NEWSWIRE) -- The "Healthcare Distribution: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Healthcare Distribution estimated at US$1.6 Trillion in the year 2022, is projected to reach a revised size of US$5.7 Trillion by 2030, growing at a CAGR of 16.9% over the analysis period 2022-2030.
Pharmaceutical, one of the segments analyzed in the report, is projected to record a 16.6% CAGR and reach US$2.3 Trillion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Biopharmaceutical segment is readjusted to a revised 18.6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $580 Billion, While China is Forecast to Grow at 19.7% CAGR
The Healthcare Distribution market in the U.S. is estimated at US$580 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1 Trillion by the year 2030 trailing a CAGR of 19.7% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.2% and 14.4% respectively over the 2022-2030 period.
Within Europe, Germany is forecast to grow at approximately 16.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$733.7 Billion by the year 2030.
Select Competitors (Total 61 Featured) -
- Accord-UK Ltd.
- ALLIANCE UNICHEM IP LIMITED
- AmerisourceBergen Corporation
- Attain Med, Inc.
- Cardinal Health, Inc.
- CuraScript SD
- Dakota Drug, Inc.
- Express Scripts Holding Company
- FedEx Corporation
- FFF Enterprises, Inc.
- Henry Schein Inc.
- KeySource Medical, Inc.
- McKesson Corporation
- Medline Industries
- Morris and Dickson Co., LLC
- Mutual Drug
- Owens & Minor, Inc.
- Patterson Companies Inc.
- PHOENIX Group
- Redington (India) Limited
- Shanghai Pharmaceutical Group Co., Ltd.
- Smith Drug Company
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 417 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $1.6 Trillion |
| Forecasted Market Value (USD) by 2030 | $5.7 Trillion |
| Compound Annual Growth Rate | 17.2% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Healthcare Distribution - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- The Race Between the Virus & Vaccines Intensifies. Amidst this Chaotic Battle, Where is the World Economy Headed in 2021?
- How Fast the World is Vaccinated Will Determine How Soon the Pandemic Will End: Global Number of Annual COVID-19 Vaccine Doses (In Million) for Years 2020 through 2025 by Geographic Region/Country
- Progress on Vaccinations, Why Should Businesses Care?
- These are Times When Questions Abound & Answers Are Few
- With IMF's Upward Revision of Global GDP Forecasts for 2021, Most Companies Are Bullish About a Global Economic Comeback.
- A Strong 2021 Economic Rebound Based On Pent-Up Demand Comes as a Relief for Suffering Industries & Markets: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
- Easing Unemployment Levels in 2021 Although Moderate Will Infuse Hope for Industries Reliant on Consumer Discretionary Incomes: Global Number of Unemployed People (In Million) for Years 2017, 2019, 2020, and 2022
- A Retrospective Review of Year 2020 as the Worst Year in Humanity's History that Left the World in Shambles & Industries and Markets Upended
- How the Healthcare Industry Has & Continues to be Impacted by the Pandemic & What's the New Normal?
- The Biggest & Worst Ever Public Health Crisis in Human History Creates a Mixed Bag of Challenges & Opportunities for the Healthcare Industry
- With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP
- Clinical Diagnostic Laboratories Work Overtime to Manage Giant Waves of COVID Infection Testing Flowing In
- Global Clinical Diagnostics Market Reset & Trajectory - Growth Outlook (In %) For Years 2019 Through 2025
- The Pandemic Triggers Shift in Consumer Behavior & Engagement With Healthcare Technologies & Services
- Healthcare Industry Pushed to Adopt Digital Technologies & Innovate to Save Lives Amid the Crisis
- Digital Health Technologies Poised to Break New Grounds Post Pandemic: Global Opportunity in Digital Health (In US$ Billion) for Years 2020, 2022, 2024 and 2026
- How COVID-19 Outbreak Sent the Healthcare Supply Chain Into a Tailspin
- Unprecedented Losses Sustained in the Supply Chain Bodes Well for Integration of Emerging Technologies like Blockchain to Enhance Resilience & Reliability: Global Losses in Supply Chain as a % of Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA) in the Year 2020
- Far-Flung Supply Chains of the Pharma Industry Cannot be Consolidated Easily & Abruptly, But the Winds of Change Blown by COVID-19 Can Be Felt: Global Number of Plants Registered with the U.S. to Supply Active Pharmaceutical Ingredients as of the Year 2020
- Healthcare Supply Chain Management Storms Into the Spotlight to Address Disruptions Posed by the Crisis
- With Smart Management of Supply Chains Being the Need of the Hour, Healthcare Supply Chain Management to Reach New Highs: Global Opportunity in Healthcare Supply Chain Management (In US$ Million) for Years 2020, 2022, 2024, 2026
- Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Substandard Drugs, an Urgent Challenge in the Supply Chain that Begs to be Addressed
- Pharmaceutical Thefts & Counterfeiting, A Persistent Challenge in Distribution That Eludes Resolution
- Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
- Storming Into the Spotlight Is the Use of Blockchain in Fighting Counterfeiting of Drugs
- Rising Incidence of Counterfeiting in the Pharmaceutical Industry Pushes Up the Urgency to Leverage the Security Benefits Promised by Blockchain: Global Number of Pharmaceutical Counterfeiting Incidents for Years 2000, 2005, 2010, 2015, 2019 & 2022
- Serialization Emerges as an Another Weapon in the Arsenal to Battle Counterfeiting
- Rising Healthcare Costs Drives Attractiveness of e-Pharmacies
- Here's How Healthcare Costs Are Outstripping Global GDP: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
- Social Distancing Amid the COVID-19 Pandemic Accelerates the Viability & Indispensability of e-Pharmacies, Fast Forwarding Growth by Over 2 Years
- Global ePharmacy Sales Breakdown (In %) by OTC Drugs & RX Drugs As of the Year 2021
- Aging Population, Rising Prevalence of Chronic Diseases & Ensuing Demand for Drugs & Medical Equipment Rank as Major Drivers of Growth in the Market
- Aging Population Steps-Up the Burden On Healthcare Systems Including Distribution: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Rising Prevalence of Chronic Diseases Amplifies Demand for Pharmaceutical Drugs & Distribution: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
- Robust Demand for Pharmaceutical Drugs Drives Growth in the Market
- Pharmaceutical Contract Manufacturing, a Barometer of the Growing Demand & Production of Drugs
- More Drugs Being Manufactured Means More Drugs in Distribution: Global Opportunity for Pharmaceutical Contract Manufacturing (In US$ Billion) for Years 2020, 2022, 2024, and 2026
- Artificial Intelligence to Revolutionize Pharmaceutical Retailing
- As the World Ramps Up Production of COVID-19 Vaccines, Distribution Emerges Into the Spotlight
- As Mass Vaccination Drives Kick-in Challenges in Covid-19 Vaccine Distribution Begin to Surface
- A Review of Vaccine Distribution Approach in the US
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/2w9fdl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
